Opko Health Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.5% | -21.1% | -20.5% | -14.5% | -44.4% | -24.2% | -23.0% | -53.2% | -22.8% | -17.5% | -15.5% | -26.6% | -21.0% | |
| 14.7% | 14.3% | 14.9% | 13.3% | 13.9% | 13.1% | 15.7% | 14.7% | 15.0% | 15.1% | 17.9% | 13.7% | 15.3% | |
| 1.8% | 1.5% | 1.5% | 1.4% | 1.6% | 1.7% | 1.7% | 1.4% | 2.0% | 2.0% | 2.2% | 1.4% | 1.8% | |
| 42.0% | 1.4% | 8.2% | 8.1% | -16.7% | -9.2% | 7.1% | -24.2% | -1.2% | -8.2% | 9.7% | -5.3% | -1.8% | |
| 2.4% | 1.7% | 2.6% | 4.0% | 4.6% | 2.9% | 2.1% | 2.1% | 2.1% | 1.8% | 1.5% | 1.8% | 1.8% | |
| -2.0% | -0.8% | -2.5% | -3.9% | 142.7% | 63.2% | 27.0% | -1.8% | 128.3% | -1.4% | -1.4% | 9.5% | 35.1% | |
| 0.0% | 0.0% | -28.8% | -0.1% | -13.7% | -9.0% | 0.0% | -11.6% | -10.1% | -9.1% | -3.8% | -8.0% | -7.9% | |
| – | – | – | – | 135.2% | -13.1% | -2.7% | -38.9% | -0.6% | -3.2% | -0.3% | 0.2% | -1.0% | |
| 1.2% | -2.1% | 11.9% | -1.2% | 118.7% | -22.0% | -2.7% | -50.7% | -10.7% | -12.4% | -4.2% | -8.0% | -9.0% | |
| 17.1% | -23.5% | -11.7% | -19.2% | 218.6% | 13.9% | 2.7% | -104.8% | 94.6% | -31.1% | -21.9% | -25.1% | 4.9% | |
| 16.2% | -22.7% | -23.0% | -18.5% | -49.0% | -27.1% | -25.2% | -55.3% | -24.9% | -19.3% | -17.0% | -28.4% | -22.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.